Therapeutic drug monitoring of vancomycin and voriconazole by liquid chromatography-tandem mass spectrometric method

Abstract

A reliable liquid chromatography-tandem mass spectrometric(LC-MS/MS) method was developed and validated for the simultaneous determination of vancomycin and voriconazole in human plasma. The analytes and internal standard 10-hydroxycarbazepine were separated at a flow rate of 0.9 mL/min using a Zorbax SB-C₁₈ column (50 mm×4.6 mm, 2.7 μm). Positive ion electrospray ionization was used to detect vancomycin, voriconazole and intrenal standard(IS) 10-hydroxycarbazepine followed by multiple reaction monitoring(MRM) of the transition at m/z 725.5→144.2, 350.3→281.0 and 253.1→208.0, respectively. The total run time for both vancomycin and voriconazole samples was 5 min; 0.30 μg/mL was the lower limit of quantification. The precision of intraday and interday was no more than 12.4%. The method was successfully and resoundingly applied in therapeutic drug monitoring of 156 patients treated with vancomycin and voriconazole.

Keywords

Liquid chromatography-tandem mass spectrometry(LC-MS/MS) / Vancomycin / Voriconazole / Therapeutic drug monitoring

References

[1] Ye Z. K., Chen Y. L., Chen K., Zhang X. L., Du G. H., He B., Li D. K., Liu Y. N., Yang K. H., Zhang Y. Y., Zhai S. D. J. Antimicrob. Chemother., 2016, 71(11): 3020.

[2] Lestner J. M., Hill L. F., Heath P. T., Sharland M. Curr. Opin. Infect. Dis., 2016, 29: 237.

[3] Elyasi S., Khalili H. Eur.^J. Clin. Pharmacol., 2016, 72: 777.

[4] van Wanrooy M. J., Rodgers M. G., Span L. F., Zijlstra J. G., Uges D. R., Kosterink J. G., van der Werf T. S., Alffenaar J. W. Ther. Drug Monit., 2016, 38: 313.

[5] Sebaaly J. C., MacVane S. H., Hassig T. B. Am.^J. Health Syst. Pharm., 2016, 73: S14.

[6] Chawla P. K., Nanday S. R., Dherai A. J., Soman R., Lokhande R. V., Naik P. R., Ashavaid T. F. Int.^J. Clin. Pharm., 2015, 37: 925.

[7] Usman M., Hempel G. Springerplus, 2016, 5: 124.

[8] Chawla P. K., Dherai A. J., Ashavaid T. F. Indian^J. Clin. Biochem., 2016, 31: 209.

[9] Hagihara M., Sutherland C., Nicolau D. P. J. Chromatogr. Sci., 2013, 51: 201.

[10] Jesus Valle M. J., Lopez F. G., Navarro A. S. J. Pharm. Biomed. Anal., 2008, 48: 835.

[11] Burkin M. A., Burkin A. A. Prikl. Biokhim. Mikrobiol., 2009, 45: 232.

[12] Smith A., Leung-Pineda V. J. Clin. Lab. Anal., 2016, 30: 411.

[13] Prommas S., Puangpetch A., Jenjirattithigarn N., Chuwongwattana S., Jantararoungtong T., Koomdee N., Santon S., Chamnanphon M., Su-kasem C. J. Clin. Lab. Anal., 2016.

[14] Oyaert M., Peersman N., Kieffer D., Deiteren K., Smits A., Allegaert K., Spriet I., van Eldere J., Verhaegen J., Vermeersch P., Pauwels S. Clin. Chim. Acta, 2015, 441: 63.

[15] Lin D., Li G., Chen L. J. Chromatogr. Sci., 2013, 51: 485.

[16] Konig K., Kobold U., Fink G., Leinenbach A., Dulffer T., Thiele R., Zander J., Vogeser M. Clin. Chem. Lab. Med., 2013, 51: 1761.

[17] Pauwels S., Vermeersch P., van Eldere J., Desmet K. Clin. Chim. Acta, 2012, 413: 740.

[18] Wang H., Wang J. Y., Wu X. P., Shen H. Y., Luo Y., Dai H. F., Mei W. L. Chem. Res. Chinese Universities, 2015, 31(1): 38.

[19] Fda U. Guidance for Industry: Bioanalytical Method Validation, 2001.